Liver metastases from colorectal cancer: Regional intra-arterial treatment following failure of systemic chemotherapy

British Journal of Cancer

Volumn 85, Issue 4, 2001, Pages 504-508

  Cyjon, A ^a   Neuman Levin, M ^b   Rakowsky, E ^a   Greif, F ^c   Belinky, A ^b   Atar, E ^b   Hardoff, R ^d   Brenner, B ^a   Sulkes, A ^a  

^a Institute of Oncology   (Israel)

^b Unit of Invasive Radiology

^c Surgery B

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colorectal cancer; Liver metastases; Regional intra arterial

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; HEPARIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FATIGUE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035902796     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1972     Document Type: Article

References (23)

1. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
2. Pilot trial of prolonged continuous infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer
3. A prospective randomized trial of regional versus systemic continuous 5-FUDR chemotherapy in the treatment of colorectal liver metastases
4. Regression models and life tables
5. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
6. Clinical pharmacology of hepatic arterial chemotherapy
7. Solid liver tumors
8. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver
9. A randomized thai of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial
10. Nonparametric estimation for incomplete observations
11. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma
12. Intrahepatic or systemic infusion of FUDR in patients with liver metastases from colorectal carcinoma. A randomized trial
13. Hepatic arterial chemotherapy in metastatic colorectal patients
14. Treatment options for patients with metastatic colorectal cancer
15. Cancer statistics, 1998
16. Meta-Analysis Group in Cancer Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
17. Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma
18. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alpha-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin
19. Design and analysis of randomized clinical thais requiring prolonged observation of each patient. II. Analysis and examples
20. Phase 11 trial of irinotecan in patients with metastatic colorectal carcinoma
21. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
22. Cisplatinum: Combination chemotherapy and cross-resistant studies with tumors of mice
23. Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil and leucovorin